4142 — Adimmune Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapNeutral

Annual balance sheet for Adimmune, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	4,437	2,891	2,973	2,470	2,457
Net Total Accounts Receivable
Net Total Receivables	110	99.6	535	1,308	188
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	5,047	3,796	4,491	4,699	3,610
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2,880	3,575	3,848	3,976	4,087
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	8,473	8,010	9,149	9,484	8,481
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	525	297	500	1,787	1,161
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	2,157	1,861	3,025	4,010	3,249
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	6,316	6,149	6,124	5,475	5,233
Total Liabilities & Shareholders' Equity	8,473	8,010	9,149	9,484	8,481
Total Common Shares Outstanding